Drug class
Indirect sympathomimetic; noradrenaline-releasing agent
Mechanism of action
Promotes release of noradrenaline from sympathetic nerve terminals and inhibits its reuptake, increasing peripheral alpha-adrenergic vasoconstrictor tone and blood pressure.
General use cases
- Treatment of orthostatic hypotension and symptomatic low blood pressure in countries where amezinium products are authorised; use and availability are jurisdiction-specific
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
